article thumbnail

Leveraging Sterile Compounding Technology and Removing Barriers to Improve Safety

Omnicell

And one of the highest areas of opportunity for human error is in the sterile compounding process. The guidelines recognize IV workflow management systems as the minimum safety standard for preparing compounded preparations and IV robotics are recommended for high volume, large batch preparations.

article thumbnail

Pharmacy Marketing: Top Blogs of 2024

DiversifyRx

For independent pharmacies, its an opportunity to: Educate your community : Many patients dont fully understand the range of services pharmacies offer, such as compounding, point-of-care testing, or functional medicine consultations. The post Pharmacy Marketing: Top Blogs of 2024 first appeared on DiversifyRx.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

IV Robotics and the Latest USP Revisions

Omnicell

Pharmacopeia (USP) published revisions to the general chapters on compounding Nonsterile <795> and Sterile <797> preparations, including robotic technology for the very first time. Sterile compounding is one of the most labor-intensive and risky areas of pharmacy.

article thumbnail

Elevating Sterile Compounding Accuracy

Omnicell

Terri Albarano, PharmD Director, Autonomous Pharmacy, Omnicell Sterile compounding safety is one of the biggest challenges for the pharmacy supply chain. Health systems are expected to compound IV preparations with increasingly complex regulations, rising drug costs, and supply disruptions. Injectable medications cause 1.2

article thumbnail

Adopting Automation Supports Safer, More Efficient Sterile Compounding

Omnicell

Dennis Wright Senior Director, Central Pharmacy Dispensing Services, Omnicell As disruption and uncertainty in the supply of IV medications from outsourced compounding facilities continues, health system pharmacies should reevaluate how they are managing sterile compounding needs. 23 at 1 pm ET.

article thumbnail

Despite Safety and Supply Challenges, Outsourcing IV Compounding Remains High

Omnicell

Stephanie Gallagher, PharmD, MBA Senior Clinical Product Marketing Manager, Omnicell The sterile compounding industry has been under great scrutiny due to alarming frequency and severity of adverse events from IV compounding, such as the New England Compounding Center catastrophe in 2012.

article thumbnail

Why IV Automation Is Critical for Sterile Compounding

Omnicell

So why, as clinicians, are we not focused on improving the documented one in 10 inaccuracies in sterile compounded products? Dave has been a leader in adoption of IV automation and will share how IV compounding robot and iv workflow solutions are improving safety and helping to reduce errors across all areas of sterile compounding.